Free 7-day Trial
All Articles and Columns »

Progenics Pharmaceuticals, Inc. (PGNX) CEO Mark Robert Baker buys 48,833 Shares

November 16, 2012 | About:
insider

insider

52 followers
CEO of Progenics Pharmaceuticals, Inc. (PGNX) Mark Robert Baker buys 48,833 shares of PGNX on 11/15/2012 at an average price of $1.69 a share.

Progenics Pharmaceuticals, Inc. has a market cap of $60.1 million; its shares were traded at around $1.89 with and P/S ratio of 0.7.

This is the annual revenues and earnings per share of PGNX over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of PGNX.


CEO Recent Trades:



  • CEO Mark Robert Baker bought 48,833 shares of PGNX stock on 11/15/2012 at the average price of 1.69. Mark Robert Baker owns at least 93,672 shares after this. The price of the stock has increased by 11.83% since.
  • CEO Mark Robert Baker bought 1,162 shares of PGNX stock on 10/24/2012 at the average price of 2.96. Mark Robert Baker owns at least 44,839 shares after this. The price of the stock has decreased by 36.15% since.
  • CEO Mark Robert Baker bought 1,036 shares of PGNX stock on 09/26/2012 at the average price of 3.32. Mark Robert Baker owns at least 43,677 shares after this. The price of the stock has decreased by 43.07% since.
  • CEO Mark Robert Baker bought 815 shares of PGNX stock on 08/22/2012 at the average price of 4.23. Mark Robert Baker owns at least 42,641 shares after this. The price of the stock has decreased by 55.32% since.
  • CEO Mark Robert Baker bought 346 shares of PGNX stock on 07/25/2012 at the average price of 10.04. Mark Robert Baker owns at least 41,826 shares after this. The price of the stock has decreased by 81.18% since.

This is the insider trade history vs. stock price of PGNX. For the complete insider trading history of PGNX, click here.




Directors and Officers Recent Trades:



  • Senior VP Medical Affairs Robert J Israel sold 1,000 shares of PGNX stock on 07/02/2012 at the average price of 9.79. Robert J Israel owns at least 35,050 shares after this. The price of the stock has decreased by 80.69% since.
  • Senior VP Medical Affairs Robert J Israel sold 1,000 shares of PGNX stock on 06/01/2012 at the average price of 8.51. Robert J Israel owns at least 38,383 shares after this. The price of the stock has decreased by 77.79% since.


For the complete insider trading history of PGNX, click here.
  • CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
  • Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
  • Double Buys:: Companies that both Gurus and Insiders are buying
  • Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.

» Take a Free Trial of Premium Membership

About the author:

insider
GuruFocus - Stock Picks and Market Insight of Gurus

Rating: 4.0/5 (2 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide